Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-006537
Filing Date
2017-02-01
Accepted
2017-02-01 09:27:36
Documents
1
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 SUBMISSION doc5.html 5  
1 FORM 5 SUBMISSION doc5.xml 5 9522
  Complete submission text file 0001209191-17-006537.txt   10860
Mailing Address 25134 RYE CANYON LOOP SUITE 300 VALENCIA CA 91355
Business Address 25134 RYE CANYON LOOP SUITE 300 VALENCIA CA 91355 6617755300
MANNKIND CORP (Issuer) CIK: 0000899460 (see all company filings)

EIN.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 150 N. ORANGE GROVE BLVD PASADENA CA 91103
Business Address
KRESA KENT (Reporting) CIK: 0001197571 (see all company filings)

Type: 5 | Act: 34 | File No.: 000-50865 | Film No.: 17563324